Código QR (código de barras bidimensional)

Lazarus Response to Tepotinib for Leptomeningeal Metastases in a Patient With MET Exon 14 Skipping Mutation–Positive Lung Adenocarcinoma: Case Report

The spread of next-generation sequencing enables clinicians to identify rare oncogene alterations, including MET exon 14 skipping mutation, in clinical practice for NSCLC. Several tyrosine kinase inhibitors for MET exon 14 skipping mutation such as capmatinib and tepotinib have elucidated their effe...

ver descrição completa

Na minha lista:
Principais autores: Taira Ninomaru, MD, Hideaki Okada, MD, Mika Fujishima, MD, PhD, Kei Irie, PhD, Shoji Fukushima, PhD, Akito Hata, MD
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2021-03-01
coleção:JTO Clinical and Research Reports
Assuntos:
Tepotinib
MET exon 14 skipping mutation
Leptomeningeal metastases
Non–small cell lung cancer
Case report
Acesso em linha:http://www.sciencedirect.com/science/article/pii/S2666364321000047
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados